Ionis Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
Last updated:
Abstract:
Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.
Status:
Application
Type:
Utility
Filling date:
13 Feb 2020
Issue date:
1 Sep 2022